Tafamidis Impurity 7 | CAS 1179721-81-3 - Request Quote
Tafamidis Impurity 7
| SZ CAT No: | SZ-T076009 |
| CAS No | 1179721-81-3 |
| Mol.F. | C14H10ClNO4 |
| Mol.Wt. | 291.7 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tafamidis Impurity 7 is chemically 4-(3-Chlorobenzamido)-3-hydroxybenzoic acid. Tafamidis Impurity 7 is supplied with detailed characterization data compliant with regulatory guideline. Tafamidis Impurity 7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tafamidis.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1179721-81-3
Purchase 1179721-81-3
Order 1179721-81-3
Enquire 1179721-81-3
price of 1179721-81-3
1179721-81-3 Supplier
1179721-81-3 Manufacturer
1179721-81-3 Exporter
buy high quality Tafamidis Impurity 7
Purchase Tafamidis Impurity 7
Tafamidis Impurity 7 suppliers
Tafamidis Impurity 7 manufacturers
Tafamidis Impurity 7 price
Order Tafamidis Impurity 7
Enquire Tafamidis Impurity 7
Tafamidis Impurity 7 cost
Tafamidis Impurity 7 Supplier
Tafamidis Impurity 7 Distributor
Tafamidis Impurity 7 for Method Validation
Tafamidis Reference Standard
Tafamidis Impurity 7 for ANDA Filing
Tafamidis Impurity 7 for Forced Degradation Studies
Tafamidis Impurity 7 Identification Standards
Tafamidis Impurity 7 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.